Fanny Rialland
About
Fanny Rialland is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health.
According to data from OpenAlex, Fanny Rialland has authored 45 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hematology, 17 papers in Public Health, Environmental and Occupational Health and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Fanny Rialland's work include Hematopoietic Stem Cell Transplantation (20 papers), Acute Lymphoblastic Leukemia research (17 papers) and Acute Myeloid Leukemia Research (13 papers). Fanny Rialland is often cited by papers focused on Hematopoietic Stem Cell Transplantation (20 papers), Acute Lymphoblastic Leukemia research (17 papers) and Acute Myeloid Leukemia Research (13 papers). Fanny Rialland collaborates with scholars based in France, Switzerland and United States. Fanny Rialland's co-authors include Patrice Chevallier, Mohamad Mohty, Thierry Guillaume, Philippe Moreau, Virginie Gandemer, Lucie Planche, Céline Bressollette‐Bodin, Claire Galambrun, Marianne Coste‐Burel and Françoise Méchinaud and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and European Journal of Cancer.
In The Last Decade
Fanny Rialland
36 papers receiving 481 citations
Peers
Fanny Rialland
Olga Militano United States
Sandeep Nagra United Kingdom
C-C Kim South Korea
Albert Esquirol Spain
Elke Dammann Germany
W-S Min South Korea
Pınar Ataca Atilla Türkiye
James Morton Australia
Samar Kulkarni United Kingdom
LA Baxter-Lowe United States
Citations per year, relative to Fanny Rialland Fanny Rialland (= 1×)
peers
Olga Militano
Countries citing papers authored by Fanny Rialland
Since
Specialization
Citations
This map shows the geographic impact of Fanny Rialland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanny Rialland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanny Rialland more than expected).
Fields of papers citing papers by Fanny Rialland
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Fanny Rialland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanny Rialland. The network helps show where Fanny Rialland may publish in the future.
Co-authorship network of co-authors of Fanny Rialland
This figure shows the co-authorship network connecting the top 25 collaborators of Fanny Rialland. A scholar is included among the top collaborators of Fanny Rialland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fanny Rialland. Fanny Rialland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Bayart, Sophie, Sophie Haro, Anne Jourdain, et al.. (2025). Polycythemia vera and essential thrombocythemia in children, still a challenge for pediatricians. European Journal of Pediatrics. 184(2). 173–173.
2.
Houdouin, Véronique, J.‐C. Dubus, Sophie Guilmin‐Crépon, et al.. (2024). Late-onset pulmonary complications following allogeneic hematopoietic cell transplantation in pediatric patients: a prospective multicenter study. Bone Marrow Transplantation. 59(6). 858–866.
3.
Locatelli, Franco, Bénedicte Bruno, Virginie Gandemer, et al.. (2024). Ruxolitinib for pediatric patients with treatment-naïve and steroid-refractory acute graft-versus-host disease: the REACH4 study. Blood. 144(20). 2095–2106.
4.
Wiedemann, Arnaud, Gérard Michel, Jean‐Hugues Dalle, et al.. (2024). Incidence and risk factors of graft failure in allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis in a nationwide pediatric cohort. A study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy. SHILAP Revista de lepidopterología. 5(6). 1295–1300.
5.
Conrad, Anne, Yves Béguin, Amandine Le Bourgeois, et al.. (2023). Mise à jour du calendrier vaccinal après allogreffe de cellules souches hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. 111(2). S40–S49.
6.
Braudeau, Cécile, Laurence Bouchet‐Delbos, Camille Lécuroux, et al.. (2023). System-level immune monitoring reveals new pathophysiological features in hepatitis-associated aplastic anemia. Blood Advances. 7(15). 4039–4045.
7.
Theisen, Olivier, Catherine Godon, Audrey Grain, et al.. (2023). Added value of molecular karyotype in childhood acute lymphoblastic leukemia. SHILAP Revista de lepidopterología. 2(6). 513–523.
8.
Rialland, Fanny, Audrey Grain, Myriam Labopin, et al.. (2022). Reduced-toxicity myeloablative conditioning regimen using fludarabine and full doses of intravenous busulfan in pediatric patients not eligible for standard myeloablative conditioning regimens: Results of a multicenter prospective phase 2 trial. Bone Marrow Transplantation. 57(11). 1698–1703.
9.
Saultier, Paul, Mathieu Simonin, Tiphaine Adam de Beaumais, et al.. (2022). Modalités pratiques de prise en charge en cours de traitement d’entretien des leucémies aiguës lymphoblastiques pédiatriques : recommandations du Comité leucémies de la Société française de lutte contre les cancers et les leucémies de l’enfant et de l’adolescent (SFCE). Bulletin du Cancer. 109(11). 1132–1143.
10.
Petit, Arnaud, Yves Bertrand, Claire Pluchart, et al.. (2021). Therapeutic approach and outcome of children with Philadelphia chromosome‐positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitors: An SFCE retrospective study. Pediatric Blood & Cancer. 69(2). e29441–e29441.
11.
Berranger, Eva de, A Charbonnier, Edgar Jost, et al.. (2021). Prise en charge de la GVH digestive aiguë : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. 108(12). S30–S38.
12.
Neven, Bénédicte, Jean‐Hugues Dalle, Claire Galambrun, et al.. (2020). Ruxolitinib in children with steroid‐refractory acute graft‐versus‐host disease: A retrospective multicenter study of the pediatric group of SFGM‐TC. Pediatric Blood & Cancer. 67(9). e28233–e28233.
13.
Rotulo, Gioacchino Andrea, Blandine Beaupain, Fanny Rialland, et al.. (2020). HSCT may lower leukemia risk in ELANE neutropenia: a before–after study from the French Severe Congenital Neutropenia Registry. Bone Marrow Transplantation. 55(8). 1614–1622.
14.
Brasme, Jean‐François, Fanny Rialland, André Baruchel, et al.. (2020). Persistent osteoarticular pain in children: early clinical and laboratory findings suggestive of acute lymphoblastic leukemia (a multicenter case-control study of 147 patients). Pediatric Rheumatology. 18(1). 1–1.
15.
Bourcier, Jessie, Florent Morio, Thomas Gastinne, et al.. (2017). Prevalence of the reversed halo sign in neutropenic patients compared with non‐neutropenic patients: Data from a single‐centre study involving 27 patients with pulmonary mucormycosis (2003‐2016). Mycoses. 60(8). 526–533.
16.
Chevallier, Patrice, Éric Hermet, Mauricette Michallet, et al.. (2016). Évaluation et prise en charge de la surcharge en fer post-greffe : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. 103(11). S255–S266.
17.
Brissot, Éolia, Fanny Rialland, Xavier Cahu, et al.. (2015). Improvement of overall survival after allogeneic hematopoietic stem cell transplantation for children and adolescents: a three-decade experience of a single institution. Bone Marrow Transplantation. 51(2). 267–272.
18.
Malard, Florent, Patrice Chevallier, Thierry Guillaume, et al.. (2014). Continuous Reduced Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Institution’s Three Decade Experience. Biology of Blood and Marrow Transplantation. 20(8). 1217–1223.
19.
Berranger, Eva de, Anthony Cousien, Arnaud Petit, et al.. (2013). Impact on long-term OS of conditioning regimen in allogeneic BMT for children with AML in first CR: TBI+CY versus BU+CY: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire. Bone Marrow Transplantation. 49(3). 382–388.
20.
Guillaume, Thierry, Béatrice Gaugler, Patrice Chevallier, et al.. (2011). Escalated lymphodepletion followed by donor lymphocyte infusion can induce a graft-versus-host response without overwhelming toxicity. Bone Marrow Transplantation. 47(8). 1112–1117.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Olga Militano Breakdown of academic impact, for papers by Sandeep Nagra Breakdown of academic impact, for papers by C-C Kim Breakdown of academic impact, for papers by Albert Esquirol Breakdown of academic impact, for papers by Elke Dammann Breakdown of academic impact, for papers by W-S Min Breakdown of academic impact, for papers by Pınar Ataca Atilla Breakdown of academic impact, for papers by James Morton Breakdown of academic impact, for papers by Samar Kulkarni Breakdown of academic impact, for papers by LA Baxter-Lowe